TRACON Pharmaceuticals (TCON) just unveiled an update.
David Lazar stepped down as Chief Business Development Officer of his company on June 19, 2024, on his own accord. His departure was not due to any conflicts with the company’s operations or management.
See more data about TCON stock on TipRanks’ Stock Analysis page.
